Best Grants for Science Research in Puerto Rico

The EPSCoR Research Infrastructure Improvement-Focused Collaborations Program (RII-FEC) aims to enhance research capabilities in eligible jurisdictions by fostering partnerships among government, higher education, and industry. This program supports interdisciplinary teams of researchers to tackle significant challenges in STEM fields, promoting diversity and broadening participation. By integrating Minority-Serving Institutions and early-career faculty from underrepresented backgrounds, RII-FEC seeks to build sustainable STEM capacity and drive impactful discoveries across regions.

The EPSCoR Research Infrastructure Improvement (RII): EPSCoR Research Fellows program, funded by the National Science Foundation (NSF), aims to enhance research capacity and workforce development in STEM. This initiative fosters collaborations between underrepresented researchers and leading institutions, providing essential resources and support. With two tracks available—one focusing on NSF and the other on NASA—this program uniquely positions Fellows to leverage transformative research experiences and contribute to sustainable advancements in their respective fields.

The Mentored Quantitative Research Development Award (K25) aims to engage skilled professionals in NIH-relevant research, enhancing their expertise in addressing health-related issues. This award supports individuals with backgrounds in quantitative sciences and engineering, providing them with dedicated time for supervised research and study. Key application deadlines span from June 2024 to February 2027, emphasizing the program's commitment to fostering innovative research in health and disease.

The Mentored Quantitative Research Development Award (K25) aims to attract researchers with quantitative science backgrounds to NIH-relevant studies. It provides support and protected time for professionals to integrate their expertise in areas like mathematics and statistics with health research. Notably, it does not support independent clinical trials, focusing instead on collaborative experiences under mentorship. The application process involves specific deadlines for submissions, including standard, renewal, and AIDS-related grants, encouraging diverse participation in significant health research.

The Ernest F. Hollings Undergraduate Scholarship offers up to $9,500 annually for two years, alongside a paid summer internship at NOAA. This program enhances students' training in oceanic and atmospheric sciences, aiming to increase public understanding and support for environmental stewardship. Eligible students must be U.S. citizens, enrolled full-time in relevant disciplines, and maintain a minimum GPA of 3.0. The experience fosters valuable skills and networks, with 100% of alumni recommending the scholarship.

The Mentored Quantitative Research Development Award (K25) aims to attract researchers in quantitative science and engineering to focus on NIH-relevant health research. This award provides protected time for supervised study and research, allowing professionals from fields like mathematics, statistics, and engineering to integrate their expertise into health-related studies. The K25 is specifically for lead investigators of independent clinical trials or related studies, fostering innovation in clinical research and career development.

The Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program, funded by the NIH, aims to enhance the biomedical research landscape by supporting resource-limited organizations. It targets domestic institutions with limited research resources and few doctoral students in biomedical fields, promoting broader participation in research and boosting administrative capacities for sponsored programs. Applications are due by 5:00 PM local time of the applicant organization, ensuring timely submissions.

The Mentored Clinical Scientist Research Career Development Award (K08) supports individuals with clinical doctoral degrees to develop their research careers in biomedical and behavioral fields. This program emphasizes a structured mentoring approach, aiming to address the nation's health-related research needs. Key application deadlines include June 12, 2024, and October 12, 2024, among others, providing opportunities for both new and renewal submissions.

The NIH R25 program promotes broad participation in the biomedical and behavioral sciences by supporting educational activities. It aims to encourage individuals from diverse and underrepresented backgrounds to engage in research through mentoring networks and research education experiences. This initiative seeks to enhance the workforce by providing opportunities for further study and career advancement in research fields, ultimately contributing to a more inclusive scientific community.

The Research Enhancement Award Program (REAP) aims to boost basic and clinical research at health professional and graduate schools that have historically received limited NIH funding. By supporting small-scale research projects led by faculty, REAP fosters student engagement in significant research endeavors, enhancing their educational experience. Eligible institutions must grant advanced degrees in health professions and have received under $6 million in NIH support in four of the last seven years, promoting broader participation in the nation's biomedical research efforts.

The NIH Mentored Patient-Oriented Research Career Development Award (K23) is designed to support the career development of individuals with clinical doctoral degrees committed to patient-oriented research. Key deadlines for standard applications include June 12, October 12, and February 12 from 2024 to 2027. Renewal and AIDS-related grant applications also have specific deadlines. This initiative aims to enhance research focused on improving patient care.

The Limited Competition K12 Mentored Research Career Development Program aims to support institutions in developing innovative career pathways for later-stage postdoctoral fellows and junior faculty. This initiative encourages applicants from those with existing Clinical and Translational Science Awards (CTSA) to foster independent research careers. By creating diverse opportunities across academia, industry, and government, the program enhances engagement in clinical and translational science research, ultimately contributing to significant advancements in health outcomes.

The SESAPS Francis Slack Award, established by the Southeastern Section of the American Physical Society, honors individuals who have selflessly contributed to advancing physics in the Southeast. It recognizes efforts in enhancing research facilities, strengthening academic departments, and fostering regional physics organizations. Nominations remain active for three years, with a focus on encouraging women and minority candidates. This prestigious award commemorates the legacy of Francis G. Slack, a pivotal figure in the development of the Southeastern Section.

The Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional) aims to foster unique hub capabilities and research platforms to tackle critical gaps in clinical and translational science. Open to eligible organizations involved in the CTSA Program, this funding opportunity is crucial for laying groundwork for future advancements across CTSA Program Hubs. Applications are due by 5:00 PM local time, with Letters of Intent encouraged 30 days prior to the deadline.

The Senior Chemists Mini Grant for Local Sections, offered by the American Chemical Society, is designed to support local events that engage senior members in innovative activities. Grants are available on a first-come, first-serve basis, and funding can be used for various events including recognition luncheons, mentoring for undergraduates, collaborative activities with younger chemists, and community support events such as science fairs.

The Limited Competition Small Grant Program under the NCATS CTSA aims to enhance the research capabilities of scholars transitioning to independent academic translational scientists. This program supports diverse clinical and translational science projects, including pilot studies and methodology development. The R03 grants are designed for short-term projects with limited resources that generate preliminary data for future R01 applications, thereby fostering innovation and advancing health research.

The NIH invites applications to study environmental factors affecting animal research rigor and reproducibility. This initiative encourages core facilities and investigators to enhance scientific understanding through modern equipment that measures various biological and behavioral variables. Proposed research must align with NIH's mission, addressing critical processes impacting multiple organ systems. The goal is to improve the reliability of animal studies by systematically evaluating extrinsic influences in biological contexts.

The Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (T35) provides funding to domestic institutions for developing research training opportunities for predoctoral students in biomedical, behavioral, and clinical research. This grant supports short-term research training for health professional students and aims to enhance their exposure to health-related sciences, fostering interest in research careers.

The Arthur C. Cope Postdoctoral Fellowship, awarded by the American Chemical Society, recognizes outstanding achievements in organic chemistry. This two-year fellowship provides $85,000 annually to early-career researchers, promoting innovative research in sustainable organic chemistry. Candidates, nominated by their mentors, must demonstrate excellence and a commitment to inclusivity in research. The fellowship encourages participation in ACS activities, fostering career development and collaboration within the scientific community.

The NIDCD Mentored Research Education Pathway (R25) aims to enhance research education for otolaryngology residents and medical students. This program provides essential career development activities and mentored research experiences, fostering a new generation of researchers in biomedical and clinical sciences. By focusing on specialized training, it supports the recruitment of individuals from diverse backgrounds into impactful research careers, ultimately benefiting the field of otolaryngology and related health sciences.

The CCS High School Chemical Safety Grant, offered by the American Chemical Society, aims to enhance chemical safety in secondary education. Educators can apply for up to $3,000 to support initiatives like curriculum integration of safety practices, advocating for safe chemical usage, and improving safety infrastructure. Eligible applicants include middle and high school science teachers in the U.S. Grants cover training, equipment, and workshops to promote a culture of safety in educational environments.

The Short-Term Research Education Program (R25) by the NIH aims to enhance diversity in health-related research by supporting educational activities. This program focuses on providing research experiences for individuals from underrepresented groups, enriching their opportunities in the biomedical field. Applications are due by 5 PM local time, with optional Letters of Intent encouraged 30 days prior to the proposal deadline. The goal is to cultivate a diverse research workforce essential for addressing health disparities.

The NIH R25 program aims to enhance inclusivity in research education by supporting activities that encourage individuals from diverse backgrounds to pursue careers in substance use and addiction sciences. This initiative focuses on skills development courses and research experiences, particularly targeting underrepresented groups in biomedical and behavioral sciences. Applications are due by 5:00 PM local time of the applicant organization, with optional Letters of Intent encouraged 30 days prior to the full proposal deadline.

The Limited Competition Small Grant Program supports NCATS CTSA Program KL2 scholars, enhancing their transition to independent academic translational scientists. This R03 funding facilitates various research projects, including pilot studies and methodology development, aimed at generating preliminary data for future R01 applications. The program is designed for short-term projects utilizing limited resources, promoting innovative research in clinical and translational science.

The NCI Pathway to Independence Award (K99/R00) supports early-stage postdoctoral researchers transitioning to independent faculty positions. This funding opportunity encourages talented individuals with clinical or research doctoral degrees to lead independent clinical trials. Applicants should aim to foster research careers in cancer control, prevention, and data sciences. This initiative provides essential support during the transition from mentored positions to independent research roles, enhancing the pool of independent investigators in cancer research.

The NCI Pathway to Independence Award (K99/R00) aims to support early-stage postdoctoral researchers transitioning to independent faculty positions. This initiative focuses on talented individuals with doctoral degrees in research or clinical fields, providing essential NCI funding during this key career juncture. Researchers engaged in cancer control, prevention, and data sciences are encouraged to apply for this opportunity, which emphasizes experimental studies with human participants, thus aligning with NIH's clinical trial definitions.

The NCI Pathway to Independence Award (K99/R00) supports early-stage postdoctoral researchers aiming to transition to independent faculty positions. It encourages candidates with doctoral degrees in research or clinical fields to apply, particularly those in cancer control and prevention. This funding opportunity facilitates a quick shift from mentored research to independent careers, providing essential support for awardees to establish competitive research programs without leading their own clinical trials.